Aliases & Classifications for Bronchial Disease

MalaCards integrated aliases for Bronchial Disease:

Name: Bronchial Disease 12 15 17
Bronchial Diseases 56 45 74
Bronchospasm 12 15
Bronchial Disorders 44
Bronchial Spasm 74

Classifications:



External Ids:

Disease Ontology 12 DOID:1176
MeSH 45 D001982
SNOMED-CT 69 41427001

Summaries for Bronchial Disease

MedlinePlus : 44 When you breathe in, the air travels down through your trachea (windpipe). It then goes through two tubes to your lungs. These tubes are your bronchi. Bronchial disorders can make it hard for you to breathe. The most common problem with the bronchi is bronchitis, an inflammation of the tubes. It can be acute or chronic. Other problems include Bronchiectasis - a condition in which damage to the airways causes them to widen and become flabby and scarred Exercise-induced bronchospasm - a breathing problem that happens when your airways shrink while you are exercising Bronchiolitis - an inflammation of the small airways that branch off from the bronchi Bronchopulmonary dysplasia - a chronic lung condition in infants, most often premature infants

MalaCards based summary : Bronchial Disease, also known as bronchial diseases, is related to bronchitis and bronchiectasis, and has symptoms including dyspnea, apnea and snoring. An important gene associated with Bronchial Disease is ELANE (Elastase, Neutrophil Expressed), and among its related pathways/superpathways are Innate Immune System and PEDF Induced Signaling. The drugs Budesonide and Tobramycin have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and trachea, and related phenotypes are hematopoietic system and immune system

Disease Ontology : 12 A lower respiratory tract disease that affects the airways leading into the lungs, which is caused due to inflammation of the bronchi and bronchioles, infection, or blockage.

Wikipedia : 77 A bronchus is a passage of airway in the respiratory system that conducts air into the lungs. The first... more...

Related Diseases for Bronchial Disease

Diseases related to Bronchial Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 197)
# Related Disease Score Top Affiliating Genes
1 bronchitis 32.4 CCL11 CXCL8 ELANE IL5 RNASE3 TNF
2 bronchiectasis 32.1 CXCL8 ELANE SERPINA3
3 asthma 31.2 ADAM33 ADRB2 CCL11 CCL5 CXCL8 CYSLTR1
4 ige responsiveness, atopic 30.7 ADRB2 IL13 IL4 IL5 MS4A2 RNASE3
5 ascaris lumbricoides infection 30.6 IL13 IL5 TSLP
6 churg-strauss syndrome 30.5 IL5 RNASE3 TNF
7 hypereosinophilic syndrome 30.4 CCL11 IL13 IL4 IL5 RNASE3
8 allergic rhinitis 30.4 CCL11 CXCL8 IL13 IL4 IL5 MS4A2
9 pulmonary tuberculosis 30.4 IFNGR1 IL4 TNF
10 rhinitis 30.3 CCL11 CCL5 CXCL8 CYSLTR1 IL13 IL4
11 respiratory failure 30.3 CXCL8 ELANE TNF
12 status asthmaticus 30.2 ADRB2 CCL5 CXCL8 ELANE IL5 RNASE3
13 interstitial lung disease 30.0 CCL5 CXCL8 IL4 TNF
14 bronchiolitis 30.0 CCL11 CCL5 CXCL8 IL13 IL4 IL5
15 allergic asthma 29.9 ADAM33 CCL11 CCL5 IL13 IL4 IL5
16 cystic fibrosis 29.7 ADRB2 CXCL8 ELANE RNASE3
17 pulmonary disease, chronic obstructive 29.6 ADAM33 ADRB2 CCL11 CCL5 CXCL8 ELANE
18 lung disease 29.5 ADRB2 CCL5 CXCL8 ELANE IL13 IL5
19 sudden infant death with dysgenesis of the testes syndrome 11.2
20 aspiration pneumonitis 11.1
21 cytokine deficiency 10.6 IL13 IL5
22 nickel allergic contact dermatitis 10.5 IL13 IL4 IL5
23 paragonimiasis 10.5 IL13 IL5 RNASE3
24 apple allergy 10.5 IL13 IL4 IL5
25 cough variant asthma 10.5 IL4 IL5 RNASE3
26 milk allergy 10.5 IL4 IL5 RNASE3
27 chronic tic disorder 10.5 IL13 IL4 IL5
28 tropical endomyocardial fibrosis 10.5 IL4 TNF
29 atopic keratoconjunctivitis 10.5 IL4 IL5 RNASE3
30 intrinsic asthma 10.5 IL4 IL5 RNASE3
31 endomyocardial fibrosis 10.5 IL4 TNF
32 strongyloidiasis 10.5 CCL11 IL13 IL5
33 papillary conjunctivitis 10.5 CCL11 CXCL8 IL4
34 enterobiasis 10.5 IL13 IL4 IL5
35 blepharoconjunctivitis 10.5 CCL11 IL4 RNASE3
36 pollen allergy 10.5 IL13 IL5 RNASE3
37 exudative glomerulonephritis 10.5 CXCL8 TNF
38 angioimmunoblastic lymphadenopathy with dysproteinemia 10.5 IL13 IL5 TNF
39 paranasal sinus disease 10.5 IL13 IL4 IL5
40 night blindness, congenital stationary, type 1a 10.5 CCL11 IL13 IL5
41 mycobacterium fortuitum 10.5 CXCL8 IFNGR1
42 loeffler endocarditis 10.5 IL5 RNASE3
43 scleritis 10.5 IL4 IL5 TNF
44 cow milk allergy 10.5 IL5 RNASE3 TNF
45 wells syndrome 10.5 CXCL8 IL5 RNASE3
46 vernal conjunctivitis 10.5 IL4 MS4A2 RNASE3
47 respiratory syncytial virus infectious disease 10.5 CCL5 IL13 IL5
48 pemphigoid gestationis 10.5 CCL11 IL5
49 bronchopulmonary dysplasia 10.5 CXCL8 ELANE RNASE3
50 tungiasis 10.5 CXCL8 IL4 TNF

Graphical network of the top 20 diseases related to Bronchial Disease:



Diseases related to Bronchial Disease

Symptoms & Phenotypes for Bronchial Disease

UMLS symptoms related to Bronchial Disease:


dyspnea, apnea, snoring, wheezing, coughing, expiratory wheeze, inspiratory wheeze

MGI Mouse Phenotypes related to Bronchial Disease:

47
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 10 ADRB2 CCL11 CCL5 CCR6 ELANE IFNGR1
2 immune system MP:0005387 9.83 ADRB2 CCL11 CCL5 CCR6 CYSLTR1 ELANE
3 digestive/alimentary MP:0005381 9.8 IFNGR1 IL13 IL33 IL4 IL5 TNF
4 respiratory system MP:0005388 9.28 CCL11 CYSLTR1 IL13 IL33 IL4 IL5

Drugs & Therapeutics for Bronchial Disease

Drugs for Bronchial Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 690)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Budesonide Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 51333-22-3 5281004 63006
2
Tobramycin Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 32986-56-4 36294 5496
3
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 51-43-4 5816
4
Bromhexine Approved Phase 4 3572-43-8
5
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 329-65-7 838
6
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 10102-43-9 145068
7
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 7487-88-9 24083
8
Ipratropium Approved, Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22254-24-6, 60205-81-4 657309 43232
9
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2921-57-5
10
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
11
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 302-25-0
12
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
13
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 1994-09-7, 94-09-7 2337
14
Remifentanil Approved Phase 4 132875-61-7 60815
15
Etomidate Approved Phase 4 33125-97-2 667484 36339
16
tannic acid Approved Phase 4,Phase 3,Phase 2,Not Applicable 1401-55-4
17
Midazolam Approved, Illicit Phase 4,Phase 1,Not Applicable 59467-70-8 4192
18
Propofol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 2078-54-8 4943
19
Cisatracurium Approved Phase 4 96946-41-7
20
Dexmedetomidine Approved, Vet_approved Phase 4 113775-47-6 5311068 68602
21
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 437-38-7 3345
22
Atracurium Approved, Experimental, Investigational Phase 4 64228-79-1 47319
23
Montelukast Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 158966-92-8 5281040
24
mometasone furoate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 83919-23-7
25
Terbutaline Approved Phase 4,Phase 3,Phase 2,Not Applicable 23031-25-6 5403
26
Omalizumab Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 242138-07-4
27
Ephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 299-42-3 9294
28
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 90-82-4 7028
29
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3,Not Applicable 93-14-1 3516
30
Procaterol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 72332-33-3 688561
31
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 53-03-2 5865
32
Lansoprazole Approved, Investigational Phase 4,Phase 3 103577-45-3 3883
33
Dexlansoprazole Approved, Investigational Phase 4,Phase 3 138530-94-6, 103577-45-3 9578005
34
Fluticasone Approved, Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 90566-53-3 62924
35
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83905-01-5 447043 55185
36
Acetylcysteine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 616-91-1 12035
37
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 100986-85-4 149096
38
Ofloxacin Approved Phase 4,Phase 3,Phase 2,Not Applicable 82419-36-1 4583
39
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-02-2 5743
40
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 1177-87-3
41
Ciclesonide Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 126544-47-6, 141845-82-1 444033
42
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 51-45-6 774
43
Citalopram Approved Phase 4,Not Applicable 59729-33-8 2771
44
Hydrocortisone Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-23-7 5754
45
Hydrocortisone acetate Approved, Vet_approved Phase 4,Phase 2,Phase 1 50-03-3
46
Aspirin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-78-2 2244
47
Amoxicillin Approved, Vet_approved Phase 4,Phase 3,Not Applicable 26787-78-0 33613
48
Metronidazole Approved Phase 4,Not Applicable 443-48-1 4173
49
Theophylline Approved Phase 4,Phase 3,Phase 2,Not Applicable 58-55-9 2153
50
Atorvastatin Approved Phase 4,Phase 2,Phase 3 134523-00-5 60823

Interventional clinical trials:

(show top 50) (show all 3187)
# Name Status NCT ID Phase Drugs
1 Comparisons of Inhaled LAMA or ICS+LABA for COPD With Bronchiectasis Unknown status NCT02546297 Phase 4 Symbicort;Tiotropium Bromide
2 Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis Unknown status NCT02507843 Phase 4 Cholecalciferol;Placebo
3 A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis Unknown status NCT01677403 Phase 4 Tobramycin;Saline
4 Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography Unknown status NCT01361984 Phase 4 Nebulized arformoterol;Salmeterol
5 Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection Unknown status NCT02054182 Phase 4 Vitamin D
6 High Flow Nasal Cannula vs Low Flow Oxygen Therapy in Bronchiolitis Unknown status NCT03015051 Phase 4 Oxygen
7 Home Oxygen Therapy in Bronchiolitis Unknown status NCT01216553 Phase 4
8 Bronchiolitis All-study, SE-Norway Unknown status NCT00817466 Phase 4 Racemic adrenaline;Isotonic saline
9 Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype Unknown status NCT01431625 Phase 4
10 Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Bronchitis Unknown status NCT03132623 Phase 4 andrographolide sulfonate;andrographolide sulfonate simulation
11 A Study of Andrographolide Sulfonate in Patients With Acute Exacerbation of Chronic Bronchitis Unknown status NCT03132610 Phase 4 andrographolide sulfonate;andrographolide sulfonate simulation
12 Treatment Efficacy of Budesonide/Formoterol in Cough Variant Asthma and Typical Asthma Patients Unknown status NCT02934945 Phase 4 budesonide 160μg/formoterol 4.5μg
13 Low Exhaled NO and ICS in Suspected Asthma Unknown status NCT02771717 Phase 4 Budesonide (Pulmicort);Placebo - dummy inhaler
14 Nebulized Magnesium Sulfate as an Adjunct to Standard Therapy in Asthma Exacerbation Unknown status NCT02584738 Phase 4 Nebulized Magnesium Sulfate;Nebulized isotonic saline;Nebulized Salbutamol;Ipratropium bromide;Methylprednisolone or Prednisolone
15 Extra-fine Formoterol/Beclomethasone in Asthmatic Crisis Unknown status NCT02345993 Phase 4 Extra fine Formoterol/Beclomethasone
16 Effect of Dexmedetomidine on Levels of Plasma Inflammatory Factor in Asthma Patients Undergoing General Anesthesia Unknown status NCT02289391 Phase 4 Anesthesia induction;Anesthesia maintenance;Assisted anesthesia
17 Comparison of Daily Mometasone Furoate Nasal Spray Alone Versus a Combination With Montelukast for Treatment of Chronic Rhinosinusitis With Asthma After Functional Endoscopic Sinus Surgery Unknown status NCT02110654 Phase 4 Montelukast;mometasone furoate nasal spray
18 Effect of Vitamin D Supplementation on the Control of Asthma in Children at a South African Academic Hospital Unknown status NCT02053402 Phase 4 Vitamin D
19 Efficacy of Bronchial Thermoplasty in Korean Unknown status NCT02031263 Phase 4
20 The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma Unknown status NCT02002754 Phase 4 Bambuterol Hydrochloride tablets
21 Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients Unknown status NCT02002715 Phase 4 Inhaled budesonide
22 Efficacy and Safety of Activation Energy Serum (AES) Versus Placebo in Persistent Asthma. Unknown status NCT01939951 Phase 4
23 Study to Assess the Efficacy and Safety of Omalizumab Treatment on ICS Reduction for Severe IgE-mediated Asthma Unknown status NCT01912872 Phase 4 Omalizumab;Budesonide;Formoterol
24 Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home Unknown status NCT01783132 Phase 4
25 Effects of Su-Huang Antitussive Capsule on Cough Variant Asthma Unknown status NCT01584804 Phase 4 Su-Huang antitussive capsule;Sugar pill
26 Assessing Decision Maker Tools for Asthma: the Asthma APGAR Unknown status NCT01446315 Phase 4
27 Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma Unknown status NCT01404013 Phase 4 ICS/LABA;Montelukast;ICS/LABA and Montelukast
28 Efficacy and Safety Study of Procaterol Hydrochloride to Treat Patients With Cough Variant Asthma (CVA) Unknown status NCT01170429 Phase 4 Procaterol hydrochloride;Meptin placebo
29 Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic Bronchitis Unknown status NCT01121016 Phase 4 Montelukast
30 Assessment of Sublingual Immunotherapy in Children Allergic to House Dust Mites Unknown status NCT01052610 Phase 4 sublingual house dust mites allergen extract;placebo in sublingual applicator
31 Concentrations of Salmeterol in Blood and Urine Unknown status NCT00914901 Phase 4 inhaled salmeterol
32 Terbutaline Concentrations in Blood and Urine Unknown status NCT00914797 Phase 4 inhaled and oral terbutaline
33 Concentrations of Formoterol in Blood and Urine Unknown status NCT00914654 Phase 4 inhaled formoterol
34 Rapid Onset Action of Salbutamol Versus Formoterol Unknown status NCT00900874 Phase 4 salbutamol;Formoterol
35 Vitamin D for the Treatment of Severe Asthma Unknown status NCT00712205 Phase 4 Placebo;Calcitriol
36 A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children Unknown status NCT00624429 Phase 4 Budesonide respules
37 Inflammatory, Functional and Image Composite Measure to Define Asthma Control Unknown status NCT00597064 Phase 4 prednisone
38 Assessment of Utility of Exhaled Nitric Oxide Measurement for Treatment Monitoring in Children With Asthma Unknown status NCT00500253 Phase 4
39 Evaluation of Efficacy of House Dust Mite Immunotherapy in Children With Bronchial Asthma Unknown status NCT00496574 Phase 4
40 Effect of Specific Immunotherapy to Dust Mites in Children With Asthma Unknown status NCT00496561 Phase 4
41 Treatment of Acute Asthma in ER With Combination of Systemic Steroids and Inhaled Steroids Unknown status NCT00397267 Phase 4 inhalation of corticosteroids
42 A Pilot Efficacy Study of Inhaled Albuterol Delivered With Akita Breath Control Unknown status NCT00385359 Phase 4 Albuterol
43 A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy. Unknown status NCT00237068 Phase 4 Lansoprazole; Solutab
44 Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID Unknown status NCT00235053 Phase 4 fluticasone/salmeterol DISKUS 250/50
45 Duration of Antibiotic Therapy in Community - Acquired Pneumonia Unknown status NCT01492387 Phase 4
46 Impact of Continuous Positive Airway Pressure on the Treatment of Acute Asthma Exacerbation Completed NCT01403467 Phase 4
47 Salmeterol-Fluticasone Combined Inhaled Therapy for Non-cystic Fibrosis Bronchiectasis Completed NCT02782312 Phase 4 ICS+LABA
48 Combivent vs. Salbutamol in Patients With Metacholine Induced Bronchospasm Completed NCT02182713 Phase 4 Salbutamol sulfate/Ipratropium bromide;Salbutamol
49 Efficacy of Azithromycin in Treatment of Bronchiectasis Completed NCT02107274 Phase 4 Azithromycin;Placebo for Azithromycin
50 Prevention of OM-85 on Bronchiectasis Exacerbation Completed NCT01968421 Phase 4 OM-85

Search NIH Clinical Center for Bronchial Disease

Inferred drug relations via UMLS 74 / NDF-RT 52 :


Cochrane evidence based reviews: bronchial diseases

Genetic Tests for Bronchial Disease

Anatomical Context for Bronchial Disease

MalaCards organs/tissues related to Bronchial Disease:

42
Lung, Testes, Trachea, Bone, T Cells, Heart, Neutrophil

Publications for Bronchial Disease

Articles related to Bronchial Disease:

(show top 50) (show all 63)
# Title Authors Year
1
Metallic small y stent placement at primary right carina for bronchial disease. ( 30497447 )
2018
2
Male patient with chronic bronchial disease and bullous emphysema superinfection. ( 29703394 )
2018
3
Novel Mutation of Interferon-γ Receptor 1 Gene Presenting as Early Life Mycobacterial Bronchial Disease. ( 27868075 )
2016
4
A case of IgG4-related bronchial disease successfully treated with inhaled corticosteroids. ( 26441152 )
2016
5
Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype. ( 24591669 )
2014
6
Progression and prognostic indicators of bronchial disease in children with sickle cell disease. ( 24699774 )
2014
7
'Heavier the interval than the consummation': bronchial disease in Seán Ó Ríordáin's diaries. ( 24002457 )
2014
8
Correlation of bronchoalveolar eosinophilic percentage with airway responsiveness in cats with chronic bronchial disease. ( 23617298 )
2013
9
Lower respiratory tract endoscopy in the cat: diagnostic approach to bronchial disease. ( 24152702 )
2013
10
Inhaled budesonide therapy in cats with naturally occurring chronic bronchial disease (feline asthma and chronic bronchitis). ( 24000786 )
2013
11
Use of propentofylline in feline bronchial disease: prospective, randomized, positive-controlled study. ( 20810552 )
2010
12
Radiographic abnormalities in cats with feline bronchial disease and intra- and interobserver variability in radiographic interpretation: 40 cases (1999-2006). ( 19210258 )
2009
13
Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicentre postmarketing study in 9657 patients. ( 16860549 )
2009
14
Tobacco as an allergen in bronchial disease. ( 17458428 )
2007
15
The nose: gatekeeper and trigger of bronchial disease. ( 17020064 )
2006
16
Twenty-five cases of feline bronchial disease (1995-2000). ( 15135355 )
2004
17
Bronchial diseases and lung aeration in children. ( 11685087 )
2001
18
Flexible bronchoscopy: a safe method for metal stent implantation in bronchial disease. ( 10735670 )
2000
19
The role of airway stents in the management of pediatric tracheal, carinal, and bronchial disease. ( 11053808 )
2000
20
Elastic deformation properties of implanted endobronchial wire stents in benign and malignant bronchial disease: A radiographic in vivo evaluation. ( 10094988 )
1999
21
Pneumocystis carinii infection in patients with chronic bronchial disease. ( 8598795 )
1996
22
Atypical bronchoplasty to lung cancer and benign bronchial disease. ( 8073432 )
1994
23
From alveoli back to bronchi. Contribution of bronchoalveolar (BAL) and bronchial (BL) lavage to the understanding of bronchial disease. International workshop. Verno, Italy, April 19-21, 1990. ( 1349762 )
1992
24
Broncholithiasis: a neglected bronchial disease in this country. Illustration of three cases. ( 1581838 )
1992
25
Clinical, radiographic, and bronchial cytologic features of cats with bronchial disease: 65 cases (1980-1986). ( 2470710 )
1989
26
Cefetamet pivoxil (Ro 15-8075) and amoxicillin in the treatment of bacterial exacerbations of chronic bronchial disease--preliminary results. ( 16312635 )
1989
27
Resection with laser and high frequency cutting loop in tracheo-bronchial diseases. ( 2715692 )
1989
28
Aspiration of solid food particles into lungs of patients with gastroesophageal reflux and chronic bronchial disease. ( 3338306 )
1988
29
Comparison of CT and fiberoptic bronchoscopy in the evaluation of bronchial disease. ( 3491497 )
1987
30
Beta-blockers and the patient with bronchial disease. ( 2879812 )
1986
31
Chronic bronchial disease of the cat. ( 3907110 )
1985
32
End-inspiratory flow reduction in the forced flow-volume curve as a sign of unilateral bronchial disease. ( 4080042 )
1985
33
No demonstrable effect of sobrerol as an expectorant in patients with stable chronic bronchial diseases. ( 3907738 )
1985
34
Angiography in chest diseases. III. Chronic bronchial diseases, inflammatory, granulomatous, and fibrosing lung diseases. ( 6507202 )
1984
35
[Lipid analysis of sputum from patients with chronic bronchial diseases]. ( 7284646 )
1981
36
Bronchial disease in ulcerative colitis. ( 7444824 )
1980
37
Treatment of bronchial diseases in pediatrics. results of the use of oral acetylcysteine in 80 cases. ( 6938399 )
1980
38
Quantitative sputum gram stains in chronic bronchial disease. ( 43418 )
1979
39
Manual and computer methods for measuring lung mechanics in children with bronchial disease. ( 752398 )
1978
40
Anaerobic bacteriology of chronic bronchial disease. With a refined method of sampling bronchial secretions. ( 588430 )
1977
41
Relationship of physical sputum characteristics and ventilatory capacity in chronic bronchial disease. ( 4695750 )
1973
42
Physical properties of sputum and respiratory function in chronic bronchial disease. ( 4778954 )
1973
43
Sputum cell dynamics in bacterial exacerbations of chronic bronchial disease. ( 5019450 )
1972
44
The pattern of bacterial infection in bronchial diseases in Australia: a serological and bacteriological survey. ( 4404399 )
1972
45
Anhidrotic ectodermal dysplasia: predisposition to bronchial disease. ( 5539281 )
1971
46
Therapy of obstructive bronchial diseases: the physicochemical approach. ( 4107526 )
1971
47
Surgery for tracheal and bronchial diseases. ( 6075625 )
1967
48
Treatment of obstructive bronchial diseases. Periarterial sympathectomy with removal of carotid body. ( 5945214 )
1966
49
A BREATHING EXERCISE PROGRAM FOR CHRONIC BRONCHIAL DISEASE AND PULMONARY EMPHYSEMA. ( 14348275 )
1965
50
NATURAL HISTORY OF PLACEBO-TREATED PATIENTS WITH CHRONIC BRONCHIAL DISEASE OBSERVED FOR 7 YEARS. ( 14288021 )
1964

Variations for Bronchial Disease

Expression for Bronchial Disease

Search GEO for disease gene expression data for Bronchial Disease.

Pathways for Bronchial Disease

Pathways related to Bronchial Disease according to GeneCards Suite gene sharing:

(show all 37)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
13.9 CCL11 CCL5 CCR6 CXCL8 ELANE ICOSLG
2
Show member pathways
13.66 CCL11 CCL5 CCR6 CXCL8 IFNGR1 IL13
3
Show member pathways
13.54 CCL11 CCL5 CXCL8 IFNGR1 IL13 IL4
4
Show member pathways
13.41 CCL11 CCL5 CCR6 CXCL8 IL13 IL4
5
Show member pathways
13.33 CCL11 CCL5 CXCL8 IFNGR1 IL13 IL33
6
Show member pathways
13.3 CCL11 CCL5 CCR6 CXCL8 IL13 IL4
7 12.84 CXCL8 IFNGR1 IL13 IL4 IL5 STAT6
8
Show member pathways
12.76 CCL11 CXCL8 ICOSLG IFNGR1 IL13 IL4
9
Show member pathways
12.62 ICOSLG IFNGR1 IL4 MS4A2 TNF
10
Show member pathways
12.61 IFNGR1 IL13 IL4 IL5 STAT6 TNF
11
Show member pathways
12.58 IL13 IL4 IL5 MS4A2 TNF
12
Show member pathways
12.4 IFNGR1 IL13 IL4 IL5 STAT6 TSLP
13
Show member pathways
12.35 CCL11 CXCL8 IL13 IL4 IL5 TNF
14
Show member pathways
12.3 CCL5 IL4 SERPINA3 TNF
15
Show member pathways
12.26 CXCL8 IL13 IL4 IL5 TNF
16
Show member pathways
12.2 IFNGR1 IL33 STAT6 TNF
17
Show member pathways
12.2 CCL11 CXCL8 IFNGR1 IL4 TNF
18
Show member pathways
12.07 CCL11 CCL5 CXCL8 IFNGR1 IL13 IL4
19
Show member pathways
12 CCL11 CCL5 CCR6 CXCL8
20 11.97 CCL11 CXCL8 IL13 IL4 STAT6 TNF
21 11.84 IL4 IL5 TNF
22 11.83 CXCL8 IL13 IL4 IL5
23 11.8 CCL5 CXCL8 TNF
24
Show member pathways
11.79 CXCL8 IL4 IL5 TNF
25 11.73 CCL11 CCL5 IL13 IL4 TNF
26 11.69 CCL11 IL4 IL5 STAT6
27 11.6 CCR6 IL13 IL33 IL4 IL5 TNF
28 11.54 CCL5 CXCL8 IL13 IL4 TNF
29 11.52 CCL11 CXCL8 STAT6 TSLP
30 11.4 CCL11 IL13 IL33 IL4 IL5 STAT6
31 11.26 IL13 IL4 IL5 TNF
32 11.22 IL13 IL4 IL5
33 11.18 CCL5 CXCL8 TNF
34 11.14 CCL11 CCL5 CXCL8 IL13 IL4 IL5
35 11.01 CCL11 CCL5 CXCL8 IL13 IL4 IL5
36 10.97 CCL11 CCL5 CXCL8 IL13 IL4 IL5
37 10.94 IL13 IL33 IL4 IL5 TNF TSLP

GO Terms for Bronchial Disease

Cellular components related to Bronchial Disease according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.73 CCL11 CCL5 CXCL8 ELANE IL13 IL33
2 external side of plasma membrane GO:0009897 9.55 CCR6 ICOSLG IL13 MS4A2 TNF
3 azurophil granule lumen GO:0035578 9.43 ELANE RNASE3 SERPINA3
4 extracellular space GO:0005615 9.4 CCL11 CCL5 CXCL8 ELANE IL13 IL33

Biological processes related to Bronchial Disease according to GeneCards Suite gene sharing:

(show all 33)
# Name GO ID Score Top Affiliating Genes
1 defense response GO:0006952 9.86 CXCL8 CYSLTR1 ICOSLG TNF
2 inflammatory response GO:0006954 9.86 CCL11 CCL5 CXCL8 IL13 IL5 MS4A2
3 cellular calcium ion homeostasis GO:0006874 9.83 CCL11 CCL5 ELANE
4 immune response GO:0006955 9.81 CCL11 CCL5 CCR6 CXCL8 IL13 IL4
5 neutrophil chemotaxis GO:0030593 9.8 CCL11 CCL5 CXCL8
6 cellular response to interleukin-1 GO:0071347 9.8 CCL11 CCL5 CXCL8
7 response to virus GO:0009615 9.8 CCL11 CCL5 IFNGR1 TNF
8 chemotaxis GO:0006935 9.8 CCL11 CCL5 CCR6 CXCL8 CYSLTR1
9 positive regulation of inflammatory response GO:0050729 9.78 IL33 TNF TSLP
10 positive regulation of cold-induced thermogenesis GO:0120162 9.78 ADRB2 IL13 IL4 STAT6
11 chemokine-mediated signaling pathway GO:0070098 9.76 CCL11 CCL5 CCR6 CXCL8
12 positive regulation of interleukin-6 production GO:0032755 9.75 IL33 TNF TSLP
13 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.73 CCL5 IL13 IL4 TSLP
14 positive regulation of B cell proliferation GO:0030890 9.71 IL13 IL4 IL5
15 positive regulation of smooth muscle cell proliferation GO:0048661 9.67 CCL5 ELANE IL13 TNF
16 dendritic cell chemotaxis GO:0002407 9.66 CCL5 CCR6
17 positive regulation of macrophage activation GO:0043032 9.65 IL13 IL33
18 negative regulation of growth of symbiont in host GO:0044130 9.65 ELANE TNF
19 negative regulation of G protein-coupled receptor signaling pathway GO:0045744 9.64 CCL5 CXCL8
20 positive regulation of immunoglobulin secretion GO:0051024 9.64 IL33 IL5
21 positive regulation of podosome assembly GO:0071803 9.63 IL5 TNF
22 neutrophil activation GO:0042119 9.62 CCL5 CXCL8
23 positive regulation of chemokine secretion GO:0090197 9.61 IL33 TNF
24 regulation of signaling receptor activity GO:0010469 9.61 CCL11 CCL5 CXCL8 IL13 IL33 IL4
25 positive regulation of interleukin-8 biosynthetic process GO:0045416 9.6 ELANE TNF
26 leukocyte migration involved in inflammatory response GO:0002523 9.59 CCR6 ELANE
27 positive regulation of interleukin-5 production GO:0032754 9.58 IL33 TSLP
28 positive regulation of neuroinflammatory response GO:0150078 9.57 IL33 TNF
29 negative regulation of complement-dependent cytotoxicity GO:1903660 9.52 IL13 IL4
30 positive regulation of isotype switching to IgE isotypes GO:0048295 9.51 IL4 STAT6